Lancet:童年患癌症经过治疗后对以后的健康情况的影响:SJLIFE研究。

2017-09-08 qinqiyun MedSci原创

从童年癌症存活下来的患者往往在早期就进展严重的慢性健康状况(CHCs)。然后,尚未有关于此类人群患病率的累积负担情况的报道。Nickhill Bhakta等人对童年癌症的长期存活者年长人群中治疗癌症的累积负担进行研究。

从童年癌症存活下来的患者往往在早期就进展严重的慢性健康状况(CHCs)。然后,尚未有关于此类人群患病率的累积负担情况的报道。Nickhill Bhakta等人对童年癌症的长期存活者年长人群中治疗癌症的累积负担进行研究。

研究人员进行一回顾性研究,收集在St Jude儿童研究医院治疗过童年癌症的、确诊后已存活10年及以上的、截至2015年6月30日年满18岁的所有患者的CHCs相关数据。并用年龄和性别匹配的社区对照作比较。21种医疗暴露被纳入分析。所有受试者的168种CHCs按照严重程度分级。

5522名在St Jude儿童研究医院治疗过童年癌症的患者有完整医疗记录、存活十年及以上、且年满18岁,其中,3010名(54.5%)仍幸存,且登记进行前瞻性临床评估。50岁时CHCs的累积发病率:CHCs1-5级是99.9%(95%CI99.9-99.9)、3-5级是96.0%(95%CI95.3-96.8)。50岁时,一名幸存者平均经历了17.1(95% CI16.2-18.1)任何等级的CHCs,其中4.7(4.6-4.9)是3-5级的CHCs。而在匹配的社区对照的CHCs1-5级的累积负担是9.2(95%CI7.9-10.6; p<0.0001),CHCa3-5级的是2.3(1.9–2.7, p<0.0001)。造成累积负担的主要原因是二次肿瘤、脊柱和肺疾病。在不同原发癌症患者中观察到显着的CHC负担分布的异质性。50岁时CHC负担的累积情况在CNS恶性肿瘤的幸存者最高(24.2[95%CI20.9–27.5]),在生殖细胞肿瘤的幸存者中最低(14.0[11.5–16.6])。

童年癌症幸存者的CHCs负担是实质性的而且高度变化。本研究对童年癌症幸存者累积负担的评估,详细描述了长期CHCs情况,并提供确切数据,以便以后更好地为该人群提供临床指导、研究调查和卫生服务规划。

原始出处:

Nickhill Bhakta,et al.The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE).The Lancet. September 07,2017.http://dx.doi.org/10.1016/S0140-6736(17)31610-0.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1829186, encodeId=b268182918603, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed Jun 27 06:25:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2068527, encodeId=eca2206852e22, content=<a href='/topic/show?id=59371088215' target=_blank style='color:#2F92EE;'>#Life#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10882, encryptionId=59371088215, topicName=Life)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Wed Dec 20 11:25:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243125, encodeId=93822431257b, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Tue Sep 12 08:15:45 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242394, encodeId=425a242394a0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Sep 10 06:53:09 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601418, encodeId=2e8c1601418aa, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Sun Sep 10 05:25:00 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242316, encodeId=375c242316e3, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sat Sep 09 23:24:28 CST 2017, time=2017-09-09, status=1, ipAttribution=)]
    2018-06-27 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1829186, encodeId=b268182918603, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed Jun 27 06:25:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2068527, encodeId=eca2206852e22, content=<a href='/topic/show?id=59371088215' target=_blank style='color:#2F92EE;'>#Life#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10882, encryptionId=59371088215, topicName=Life)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Wed Dec 20 11:25:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243125, encodeId=93822431257b, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Tue Sep 12 08:15:45 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242394, encodeId=425a242394a0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Sep 10 06:53:09 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601418, encodeId=2e8c1601418aa, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Sun Sep 10 05:25:00 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242316, encodeId=375c242316e3, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sat Sep 09 23:24:28 CST 2017, time=2017-09-09, status=1, ipAttribution=)]
    2017-12-20 clmlylxy
  3. [GetPortalCommentsPageByObjectIdResponse(id=1829186, encodeId=b268182918603, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed Jun 27 06:25:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2068527, encodeId=eca2206852e22, content=<a href='/topic/show?id=59371088215' target=_blank style='color:#2F92EE;'>#Life#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10882, encryptionId=59371088215, topicName=Life)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Wed Dec 20 11:25:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243125, encodeId=93822431257b, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Tue Sep 12 08:15:45 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242394, encodeId=425a242394a0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Sep 10 06:53:09 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601418, encodeId=2e8c1601418aa, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Sun Sep 10 05:25:00 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242316, encodeId=375c242316e3, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sat Sep 09 23:24:28 CST 2017, time=2017-09-09, status=1, ipAttribution=)]
    2017-09-12 lietome24

    好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛.

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1829186, encodeId=b268182918603, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed Jun 27 06:25:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2068527, encodeId=eca2206852e22, content=<a href='/topic/show?id=59371088215' target=_blank style='color:#2F92EE;'>#Life#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10882, encryptionId=59371088215, topicName=Life)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Wed Dec 20 11:25:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243125, encodeId=93822431257b, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Tue Sep 12 08:15:45 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242394, encodeId=425a242394a0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Sep 10 06:53:09 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601418, encodeId=2e8c1601418aa, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Sun Sep 10 05:25:00 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242316, encodeId=375c242316e3, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sat Sep 09 23:24:28 CST 2017, time=2017-09-09, status=1, ipAttribution=)]
    2017-09-10 yfjms

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1829186, encodeId=b268182918603, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed Jun 27 06:25:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2068527, encodeId=eca2206852e22, content=<a href='/topic/show?id=59371088215' target=_blank style='color:#2F92EE;'>#Life#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10882, encryptionId=59371088215, topicName=Life)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Wed Dec 20 11:25:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243125, encodeId=93822431257b, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Tue Sep 12 08:15:45 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242394, encodeId=425a242394a0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Sep 10 06:53:09 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601418, encodeId=2e8c1601418aa, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Sun Sep 10 05:25:00 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242316, encodeId=375c242316e3, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sat Sep 09 23:24:28 CST 2017, time=2017-09-09, status=1, ipAttribution=)]
    2017-09-10 lq0307
  6. [GetPortalCommentsPageByObjectIdResponse(id=1829186, encodeId=b268182918603, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed Jun 27 06:25:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2068527, encodeId=eca2206852e22, content=<a href='/topic/show?id=59371088215' target=_blank style='color:#2F92EE;'>#Life#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10882, encryptionId=59371088215, topicName=Life)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Wed Dec 20 11:25:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243125, encodeId=93822431257b, content=好文.值得点赞!认真学习了.把经验应用于实践.为患者解除病痛., beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Tue Sep 12 08:15:45 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242394, encodeId=425a242394a0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Sep 10 06:53:09 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601418, encodeId=2e8c1601418aa, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Sun Sep 10 05:25:00 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242316, encodeId=375c242316e3, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sat Sep 09 23:24:28 CST 2017, time=2017-09-09, status=1, ipAttribution=)]
    2017-09-09 luominglian113

    学习了.谢谢分享

    0

相关资讯

看完《奇异博士》,学医人的童年全毁了!

1、流行性感冒普通感冒主要表现为喷嚏、流涕等上呼吸道症状,全身症状较轻,不发热或仅有低热,一般3至5天痊愈。而流感起病急,具有较强的传染性,表现全身症状较重,突然畏寒、发热、头痛、全身酸痛、鼻塞、流涕、干咳、胸痛、恶心、食欲不振,婴幼儿或老年人可能并发肺炎或心力衰竭。2、急性细菌性鼻窦炎致病菌多为肺炎链球菌、流感嗜血杆菌、葡萄球菌、大肠杆菌及变形杆菌等,临床多见混合感染。多在病毒性上呼吸道感染后症

Biology letters:童年失去父亲真的会让女孩子过早地性成熟吗?

父亲(母亲)的离开能够促进儿童的性成熟吗?一些科学家人们答案是肯定的,他们的看法是基于进化学的理论。然而,最近一项大规模的研究显示,儿童性成熟更依赖于父母亲离开的具体方式。 进化心理学家预测失去父母亲的儿童能够发育的更快,他们离开的事实仿佛告诉他们一些信息:生活之路并不平坦,因此一个最佳的繁殖策略便诞生了:要尽早地繁殖后代,因为你极有可能跟你的父母亲一样早早地去世。这一策略像是一类可预测性的

BMJ:童年时智商越高,寿命就越长

《英国医学杂志》今天发表的一项研究发现,童年时高智商(IQ)与其一生中主要死亡原因风险较低有关。所谓主要死亡原因包括心脏病、中风、吸烟相关性癌症、呼吸系统疾病及老年痴呆症。

BMJ:童年被恐吓,容易引起成年后抑郁症

研究显示,儿童在青少年时期受到同伴的恐吓后会极大程度提高他们成年后患抑郁症的风险。这项研究由来自英国牛津大学的研究者们完成,他们发现小孩子如果在13岁左右经常受到同班的威胁恐吓,那么他们在刚成年时抑郁的几率相比于其它同龄人要高一倍左右。“我们的研究证明刚成年的孩子患抑郁症,其中很大一部分源于同伴的威胁,这两者之间存在因果关系,”该研究的首席研究员Lucy Bowes博士说到。“我们的研究同时发现大

Lancet Public Health:人生早期的创伤相关入院经历与日后自我伤害和人际暴力发生风险的研究

更好地了解那些在童年时经历了心理创伤个体的后续经历可能有助于临床医生和公共卫生专业人员了解自我伤害和人际暴力的原因。研究者的目的是评估这类人群(童年有因伤害或中毒而入院的个体)在他们青少年和成年早期自我伤害和人际暴力的风险。

Lancet:童年受欺凌会影响成年后心理健康

    童年虐待对其成人心理健康的影响是有据可查的。被同龄人虐待(即,欺凌)也被证明有长期的不利影响。我们的目的是判断这些影响是否仅仅是由于暴露于虐待和欺凌或欺凌是否有独特的效果。    我们使用的数据来自于英国父母和儿童的Avon纵向研究(ALSPAC)和美国Great Smoky Mountains(GSMS)纵向研究。在在ALSPAC,虐待被评定为身体